Skip to main content
Watch Insiders
DFTX filings

Corporate insider profile

Robert Barrow Filing Activity

Latest reported as Chief Executive Officer of Definium Therapeutics, Inc. (DFTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,036,968.86
Latest transaction
Sep 3, 2026

Affiliated corporations

Reported company relationships

DFTXLatest reported

Definium Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 3, 2026Definium Therapeutics, Inc. (DFTX)Chief Executive OfficerSale19,023$37.94$721,733
Jun 25, 2026Definium Therapeutics, Inc. (DFTX)Chief Executive OfficerSale29,208$45.03$1,315,236